未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists A Cost-Effectiveness Study
Choi, Jin G.; Winn, Aaron N.; Skandari, M. Reza; Franco, Melissa, I; Staab, Erin M.; Alexander, Jason; Wan, Wen; Zhu, Mengqi; Huang, Elbert S.; Philipson, Louis; Laiteerapong, Neda
分享
收藏Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis
Alexander, Jason T.; Staab, Erin M.; Wan, Wen; Franco, Melissa; Knitter, Alexandra; Skandari, M. Reza; Bolen, Shari; Maruthur, Nisa M.; Huang, Elbert S.; Philipson, Louis H.; Winn, Aaron N.; Thomas, Celeste C.; Zeytinoglu, Meltem; Press, Valerie G.; Tung, Elizabeth L.; Gunter, Kathryn; Bindon, Brittany; Jumani, Sanjay; Laiteerapong, Neda
分享
收藏The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis胰高血糖素样肽-1受体激动剂的长期益处和危害: 系统评价和荟萃分析
Alexander, Jason T.; Staab, Erin M.; Wan, Wen; Franco, Melissa; Knitter, Alexandra; Skandari, M. Reza; Bolen, Shari; Maruthur, Nisa M.; Huang, Elbert S.; Philipson, Louis H.; Winn, Aaron N.; Thomas, Celeste C.; Zeytinoglu, Meltem; Press, Valerie G.; Tung, Elizabeth L.; Gunter, Kathryn; Bindon, Brittany; Jumani, Sanjay; Laiteerapong, Neda
分享
收藏